Acutaas Chemicals Ltd Q1 FY27 Results Analysis: PAT Surges 68%, Margin Compresses 811 bps QoQ

Acutaas Chemicals Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 329.67 Cr (+59.08% YoY) and PAT growth of +67.67% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

ACUTAAS delivered strong YoY revenue growth of 59% and PAT growth of 68%, with EBITDA margin expanding 974 bps YoY. However, the quarter saw a sharp sequential decline of 24% in revenue and an 811 bps QoQ margin compression, driven by higher raw material costs and employee expenses. No management guidance or forward-looking commentary was provided, limiting visibility on future trajectory.

Key Investment Insights

Key Positives

• Consolidated revenue grew 59.08% YoY to Rs.329.67 Cr from Rs.207.24 Cr in Q1FY26
• PAT (owners) grew 67.67% YoY to Rs.74.26 Cr from Rs.44.29 Cr
• EBITDA margin expanded 974 bps YoY to 34.30% from 24.56%
• EBITDA grew 122.10% YoY to Rs.113.07 Cr from Rs.50.91 Cr
• Effective tax rate remains moderate at 27.83%

Risk Factors

• Revenue declined 23.82% QoQ from Rs.432.75 Cr in Q4FY26, a sharp sequential drop
• EBITDA margin compressed 811 bps QoQ from 42.41% to 34.30%
• Cost of materials as % of revenue rose 8pp QoQ to 50.28%, pressuring gross margins
• Employee benefits expense grew 18.86% QoQ, indicating rising fixed cost base from capex expansion